ISPOR Europe 2023
12 - 15 November
Program Committee
Say “hello” to this year’s Program Committee! ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to attendees.
Co-Chairs
Adrian Griffin, MSc
VP HTA & Market Access, Johnson & Johnson, United Kingdom
VP HTA & Market Access, Johnson & Johnson, United Kingdom
.jpg?sfvrsn=8797343a_0&MaxWidth=120&MaxHeight=250&ScaleUp=false&Quality=High&Method=ResizeFitToAreaArguments&Signature=CCB93098C21BB8D2CBEF5D4BC92FDD1DE038DEFA "Anja Schiel")
Anja Schiel, PhD
Special Adviser, Lead Methodologist in Regulatory and Pharmacoeconomic Statistics, Norwegian Medicines Agency, Norway
Special Adviser, Lead Methodologist in Regulatory and Pharmacoeconomic Statistics, Norwegian Medicines Agency, Norway
.jpg?sfvrsn=e0f99569_0&MaxWidth=120&MaxHeight=500&ScaleUp=false&Quality=High&Method=ResizeFitToAreaArguments&Signature=333327AADFC5760E0799932E80BFF09C2A19AD87 "Steffen Thistrup")
Steffen Thirstrup, MD, PhD
Chief Medical Officer, European Medicines Agency (EMA), Amsterdam, the Netherlands
Chief Medical Officer, European Medicines Agency (EMA), Amsterdam, the Netherlands
Members
Tamàs Àgh, MD, MSc, PhD
Research Associate Professor, University of Pècs, Pècs & Syreon Research Institute, Budapest, Hungary
Research Associate Professor, University of Pècs, Pècs & Syreon Research Institute, Budapest, Hungary
Bryan Bennett, PhD
WWHEOR PRO Asset/Indication Lead, Bristol Myers Squibb, England, United KingdomSofie Berghuis
Market Access Manager, GSK, the Netherlands
Market Access Manager, GSK, the Netherlands
Imre Boncz, MD, MSc, PhD, Habil
Professor & Director, University of Pécs, Pécs, Hungary
Professor & Director, University of Pécs, Pécs, Hungary
Jacoline Bouvy, MSc, PhD
Program Director Medicines Evaluation, NICE, London, United Kingdom
Program Director Medicines Evaluation, NICE, London, United Kingdom
Thor-Henrik Brodtkorb, PhD
Executive Director, Health Economics, RTI Health Solutions, Ljungskile, Sweden
Executive Director, Health Economics, RTI Health Solutions, Ljungskile, Sweden
Brian Buysse, PhD
Senior Director Epidemiology, Syneos Health, Spain
Senior Director Epidemiology, Syneos Health, Spain
Bill Byrom, PhD
Vice President, Product Intelligence and Positioning, Signant Health, London, United Kingdom
Vice President, Product Intelligence and Positioning, Signant Health, London, United Kingdom
Isaac Corro Ramos, MSc
Scientific Researcher, Institute for Medical Technology Assessment, The Netherlands
Scientific Researcher, Institute for Medical Technology Assessment, The Netherlands
Koen Degeling, BSc, MSc, PhD
Research Scientist, Lumen Value & Access, The Netherlands
Research Scientist, Lumen Value & Access, The Netherlands
Ramiro Eugenio Gilardino, MHA, MSc, MD
Global HTA & Access Policy Leader, MSD Innovation & Development, GmbH, Zurich, Switzerland
Global HTA & Access Policy Leader, MSD Innovation & Development, GmbH, Zurich, Switzerland
Michael Herdman, MSc
Head of Health Outcomes, Office of Health Economics, Spain
Head of Health Outcomes, Office of Health Economics, Spain
Iñaki Imaz-Iglesia, MD, PhD, MPH
Researcher, Health Technology Assessment Agency, Institute of Health “Carlos III” (AETS-ISCIII), Madrid, Spain
Researcher, Health Technology Assessment Agency, Institute of Health “Carlos III” (AETS-ISCIII), Madrid, Spain
Seamus Kent, MSc, PhD
Lead, HTA, Flatiron, the Netherlands
Lead, HTA, Flatiron, the Netherlands
Saskia Knies, PhD
Senior Advisor Health Economics and Personalized Medicine, National Health Care Institute, Diemen, the Netherlands
Senior Advisor Health Economics and Personalized Medicine, National Health Care Institute, Diemen, the Netherlands
Irina Kinchin, MSc, PhD
Research Assistant Professor, Trinity College Dublin, Dublin, Ireland
Research Assistant Professor, Trinity College Dublin, Dublin, Ireland
Ka Keat Lim, MPharm, MSc, PhD
Research Fellow, King’s College London, London, United Kingdom
Research Fellow, King’s College London, London, United Kingdom
Laura McCullagh, BSc (PHarm), PhD
Head of Research, Chief I Pharmacist, National Centre for Pharmacoeconomics, Ireland & Clinical Senior Lecturer, Pharmacology & Therapeutics, Trinity College Dublin
Head of Research, Chief I Pharmacist, National Centre for Pharmacoeconomics, Ireland & Clinical Senior Lecturer, Pharmacology & Therapeutics, Trinity College Dublin
Oresta Piniazhko, PhD
Director of HTA Department, SEC of Ministry of Health of Ukraine, Ukraine
Director of HTA Department, SEC of Ministry of Health of Ukraine, Ukraine
Thomas Rapp, PhD
Professor, Université Paris Cité (LIRAES), Co-director of the Health Policy Research Program, Sciences Po (LIEPP), Senior Advisor, Cepton-Vintura, Paris, France
Professor, Université Paris Cité (LIRAES), Co-director of the Health Policy Research Program, Sciences Po (LIEPP), Senior Advisor, Cepton-Vintura, Paris, France
Delphine Saragoussi, MSPH, MD
Executive Director, Research Science, Evidera, Paris, France
Executive Director, Research Science, Evidera, Paris, France
Vanessa Schaub, PhD
Global Access Evidence Enabler HTA Strategy, F. Hoffmann La Roche, Basel, Switzerland
Global Access Evidence Enabler HTA Strategy, F. Hoffmann La Roche, Basel, Switzerland
Anne Spencer
Professor, University of Exeter, Exeter, United Kingdom
Professor, University of Exeter, Exeter, United Kingdom
Mehtap Tatar, PhD
Director, Polar Health Economics and Policy Consultancy, Turkey
Director, Polar Health Economics and Policy Consultancy, Turkey
Praveen Thokala, MASc, PhD
Senior Research Fellow, School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, United Kingdom
Senior Research Fellow, School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, United Kingdom
Yves Verboven, MSc, Ir
Founder, EU4HealthSolutions, Belgium
Founder, EU4HealthSolutions, Belgium
Ian Watson
Senior Technical Adviser – Methods, NICE, London, United Kingdom
Steffen Wahler, MD
CEO, St. Bernward GmbH, Germany
CEO, St. Bernward GmbH, Germany
Nicky J Welton, PhD
Professor, Statistical and Health Economic Modelling, Director, NICE Guidelines Technical Support Unit, co-Director, Bristol Technology Assessment Group, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Professor, Statistical and Health Economic Modelling, Director, NICE Guidelines Technical Support Unit, co-Director, Bristol Technology Assessment Group, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Sorrel Wolowacz, PhD
Head, European Health Economics, RTI Health Solutions, Manchester, United Kingdom
Head, European Health Economics, RTI Health Solutions, Manchester, United Kingdom
Olivia Wu, PhD, MSc
Professor, Director of Health Economics and Health Technology Assessment (HEHTA) Research Group, University of Glasgow, Scotland, United Kingdom
Professor, Director of Health Economics and Health Technology Assessment (HEHTA) Research Group, University of Glasgow, Scotland, United Kingdom